NCT05117047

Brief Summary

The investigators established three prospective cohorts of patients with BCLC stage 0-A HCC, based on different surgical approaches (open, laparoscopic and robotic). After 5 years of follow-up, the investigators used propensity score matching (PSM) to reduce selection bias and then compared the long-term oncological outcomes of the three different surgical approaches, which might provide high-level evidence in non-randomized observational studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
369

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2015

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 3, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 11, 2021

Completed
Last Updated

November 11, 2021

Status Verified

November 1, 2021

Enrollment Period

2.4 years

First QC Date

November 3, 2021

Last Update Submit

November 10, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Overall Survival

    The primary outcomes of this study included long-term oncological outcomes of OS

    14/02/2015-30/06/2021

  • Disease free Survival

    The primary outcomes of this study included long-term oncological outcomes of DFS

    14/02/2015-30/06/2021

Secondary Outcomes (2)

  • postoperative complications

    14/02/2015-30/06/2021

  • Textbook Outcome in liver surgery (TOLS)

    14/02/2015-30/06/2021

Study Arms (3)

robot-assisted liver resection

In this study, the investigators included all HCC patients with BCLC stage 0-A (n=1669) who underwent hepatectomy over an 1 ½ year study period, and divided them into three study cohorts according to the operations they received. These were consecutive patients who met the inclusion criteria of the study. 71 HCC patients were included in robotic liver resection cohort.

Procedure: liver resection

laparoscopic liver resection

In this study, the investigators included all HCC patients with BCLC stage 0-A (n=1669) who underwent hepatectomy over an 1 ½ year study period, and divided them into three study cohorts according to the operations they received. These were consecutive patients who met the inclusion criteria of the study. 141 HCC patients were included in laparoscopic liver resection cohort.

Procedure: liver resection

open liver resection

In this study, the investigators included all HCC patients with BCLC stage 0-A (n=1669) who underwent hepatectomy over an 1 ½ year study period, and divided them into three study cohorts according to the operations they received. These were consecutive patients who met the inclusion criteria of the study. 157 HCC patients were included in open liver resection cohort.

Procedure: liver resection

Interventions

After adequate periods of follow-up, the long-term oncological outcomes of the three different surgical approaches were compared, providing a higher level of evidence using a non-randomized comparative study based on propensity score matching (PSM) analysis.

laparoscopic liver resectionopen liver resectionrobot-assisted liver resection

Eligibility Criteria

Age14 Years - 75 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1669 cases underwent liver resection from July 1st 2015 to June 30th 2017 in Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, including 186 RALR, 527 LLR, and 956 OLR. Among these patients, there were 102, 333, and 669 HCC patients, respectively. Ten patients were excluded due to missing data or follow-up. Finally, 369 HCC patients in the early stages were included in the analysis. After PSM, 168 patients were matched and there were 56 patients in each group

You may not qualify if:

  • with any history of malignant tumors; with treatment of ablation, TACE or TKI history before liver resection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430030, China

Location

MeSH Terms

Interventions

Hepatectomy

Intervention Hierarchy (Ancestors)

Digestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Xiaoping Chen, Dr

    Tongji Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 3, 2021

First Posted

November 11, 2021

Study Start

February 14, 2015

Primary Completion

June 30, 2017

Study Completion

June 30, 2021

Last Updated

November 11, 2021

Record last verified: 2021-11

Locations